Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc.filedCriticalPfizer Products Inc.
Publication of YU79401ApublicationCriticalpatent/YU79401A/sh
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Ovaj pronalazak se odnosi na nove derivate 1-trifluorometil-4-hidroksi-7-piperidinil-aminometilhromana formule (I) u kojima je R1 C1-C6 alkil; R2 je vodonik C1-C6 alkil, halo C1-C6 alkil ili fenil; R3 je vodonik ili halo; i R4 i R5 su nezavisno vodonik, C1-C6 aalkil ili halo C1-C6 alkil, njihove farmaceutski prihvatljive soli, farmaceutske kompozicije koje sadrže takva jedinjenja i upotrebu takvih jedinjenja u lečenju CNS, gastrointestinalnih i drugih poremećaja.[This invention relates to novel 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives of formula (I) wherein R1 is C1-C6 alkyl; R2 is hydrogen, C1-C6 alkyl, halo C1-C6 alkyl or phenyl; R3 is hydrogen or halo; and R4 and R5 are independently hydrogen, C1-C6 alkyl or halo C1-C6 alkyl, their pharmaceutically acceptable salts, pharmaceutical compositions containing such compounds, and the use of such compounds to treat CNS, gastrointestinal and other disorders.